
⸺ Celvora
Synthetic fragment of Thymosin Beta-4 studied for cell migration, tissue organisation and recovery research.
Size
Secure checkout. Free shipping on orders over £100.
Independently tested
COA on request
Fast dispatch
Order before 2pm
Research use only
Not for human consumption
⸺ Overview
TB-500 is a synthetic peptide based on the active region of Thymosin Beta-4.
⸺ Mechanism of Action
TB-500 binds and sequesters G-actin, regulating actin filament dynamics inside cells.
⸺ Research
Preclinical work in injury and wound-healing models describes improved cell migration.
Animal studies have observed reductions in local inflammatory markers.
TB-500 has been studied in cardiac injury models.
⸺ Details

Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied for appetite control, energy expenditure and glucose balance.

Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.

Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.